ZYNE
Zynerba Pharmaceuticals, Inc
ZYNE
ZYNE
Delisted
ZYNE was delisted on the 10th of October, 2023.
66 hedge funds and large institutions have $16.2M invested in Zynerba Pharmaceuticals, Inc in 2020 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 13 increasing their positions, 29 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less first-time investments, than exits
New positions opened: | Existing positions closed:
55% less repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 29
Holders
66
Holding in Top 10
–
Calls
$1.4M
Puts
$1.24M
Top Buyers
| 1 | +$180K | |
| 2 | +$171K | |
| 3 | +$158K | |
| 4 |
Group One Trading
Chicago,
Illinois
|
+$137K |
| 5 |
JWCA
J.W. Cole Advisors
Tampa,
Florida
|
+$123K |
Top Sellers
| 1 | -$2.18M | |
| 2 | -$1.3M | |
| 3 | -$1.16M | |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$559K |
| 5 |
Jane Street
New York
|
-$466K |